SIERRA VILMAR: Open Payments
NPI 1922727627 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,135 in 102 payments from 41 companies in 2025. Trend: 2023 $809 · 2024 $1,465 · 2025 $2,135
Food & beverage: $2,057Education: $78
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 7 | $210 |
| Novartis Pharmaceuticals Corporation | 9 | $162 |
| Janssen Biotech, Inc. | 10 | $145 |
| Genentech USA, Inc. | 7 | $129 |
| Merck Sharp & Dohme LLC | 2 | $122 |
| Exelixis Inc. | 5 | $99 |
| AstraZeneca Pharmaceuticals LP | 5 | $98 |
| PFIZER INC. | 6 | $96 |
| ABBVIE INC. | 4 | $89 |
| Celgene Corporation | 3 | $65 |
Products named: Enhertu, KEYTRUDA, CABOMETYX, RYBREVANT, REBLOZYL, Itovebi, IBRANCE, KISQALI.
Industry payments across LA — which companies pay providers there.
